Stay updated on Biomarker Response to Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Biomarker Response to Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Biomarker Response to Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Added and updated study locations (Colorado, Maryland, Michigan, Ontario, Quebec, Gran Canaria, Madrid) and reorganized site listings. The page revision label changed to v3.3.3.
    Difference
    0.8%
    Check dated 2025-12-23T21:04:43.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    Updated Publications section wording to clarify that publications are provided by the submitting party and pertain to study results. Added template revision indicator Revision: v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T10:18:14.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Removal of the government funding/operating status notice from the page; it does not affect trial details or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T06:46:54.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Core study information such as design, eligibility criteria, primary/secondary outcomes, and locations appears unchanged; only formatting and non-substantive details seem updated. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T20:40:49.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    - Added a government-funding notice about potential delays and updated operating status guidance, and a major version bump to v3.2.0. - Removed the previous version tag v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T04:51:13.000Z thumbnail image
  9. Check
    94 days ago
    Change Detected
    Summary
    - Version indicator updated from v3.0.2 to v3.1.0, signaling a new release.
    Difference
    0.1%
    Check dated 2025-09-29T02:55:40.000Z thumbnail image

Stay in the know with updates to Biomarker Response to Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Biomarker Response to Pembrolizumab in NSCLC Clinical Trial page.